Order Article Reprints

Dijkstra M, Nieuwenhuizen S, Puijk RS, Timmer FEF, Geboers B, Schouten EAC, Opperman J, Scheffer HJ, de Vries JJJ, Versteeg KS, et al. Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE). Biomedicines. 2021; 9(8):962. https://doi.org/10.3390/biomedicines9080962

Dijkstra, Madelon, Sanne Nieuwenhuizen, Robbert S. Puijk, Florentine E. F. Timmer, Bart Geboers, Evelien A. C. Schouten, Jip Opperman, Hester J. Scheffer, Jan J. J. de Vries, Kathelijn S. Versteeg, and et al. 2021. "Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE)" Biomedicines 9, no. 8: 962. https://doi.org/10.3390/biomedicines9080962

Dijkstra, M., Nieuwenhuizen, S., Puijk, R. S., Timmer, F. E. F., Geboers, B., Schouten, E. A. C., Opperman, J., Scheffer, H. J., de Vries, J. J. J., Versteeg, K. S., Lissenberg-Witte, B. I., van den Tol, M. P., & Meijerink, M. R. (2021). Primary Tumor Sidedness, RAS and BRAF Mutations and MSI Status as Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Surgery and Thermal Ablation: Results from the Amsterdam Colorectal Liver Met Registry (AmCORE). Biomedicines, 9(8), 962. https://doi.org/10.3390/biomedicines9080962